"Laripront" amaphilisi-mbumbulu. Imiyalelo mayelana izinkomba kanye contraindications ukusetshenziswa

Tablets "Laripront '- omunye spectrum ezibanzi izidakamizwa, okuyinto esetshenziswa inflammations ezihlukahlukene ngalo ingaphakathi ngomlomo omsakazo ahlukahlukene. Izingxenye kusho "Laripront" - dequalinium chloride futhi lysozyme hydrochloride, zivimbela ukukhula kwamagciwane, amagciwane kanye Candida isikhunta, ukusatshalaliswa okuyinto evame imbangela izinqubo ezihlukahlukene ukuvuvukala emlonyeni, pharynx futhi amalaka ngokumelene ukwehla ekhonweni lomzimba lokukwazi ukuba simelane isifo.

Ikakhulukazi, amazwana ukuze amaqembu ehlukahlukene "Laripront" amaphilisi ukukhululwa Umhlahlandlela uchaza ukuthi hydrochloride enzyme lysozyme, uxhumana amagciwane, kunciphisa ikhono lazo ukungena khona, ngaleyo ndlela ezikhandla isenzo elwa namagciwane.

Umthelela elwa namagciwane izidakamizwa ngenxa, ngakolunye uhlangothi, ikhono dequalinium chloride ukunciphisa ukungezwani surface, futhi ngakolunye - imithelela lysozyme eyenza umuntu acabange eseZwini ngokusebenzisa ingxenye yokuqala ngokusebenzisa cell ulwelwesi kanye zivimbela ukukhula microorganism Gram-HIV futhi Gram-negative, kanye nemiklamo fungal bembonisa Ngalokhu izakhiwo isinqandakuvunda.

Ngaphezu kwalokho antiinflammatory, lysozyme has futhi umphumela mucolytic futhi haemostatic ngu ivimbela histamine, heparin futhi ukusivala eqhekeza mucopolysaccharides.

Zonke lezi izakhiwo ukunquma nobubanzi ububanzi "Laripront" ukulungiselela imfundo okuyinto liyala ukuyisebenzisa for ekwelapheni uhla izifo ngomlomo, pharynx futhi amalaka. okungukuthi:

• umphimbo obuhlungu;
• namathansela;
• laryngitis;
• umphimbo obuhlungu;
• ukuvuvukala Periodontal;
• stomatitis;
• ukulungiselela ukuhlinzwa kule ngalo ingaphakathi ngomlomo kanye inkathi nasezinkingeni ezilandela ngemva kokuhlinzwa.

Tablets "Laripront" - yokusetshenziswa

Thatha lesi sidakamizwa "Laripront" kuyadingeka, 1 ithebhulethi njalo ngemva kwamahora amabili, baligcine emlonyeni noma ngaphansi impande ulimi kuze ancibilikisa ngokuphelele.

Kepha contraindications Laripront amanxusa ' "imfundo ekutshela ukuthi kungenzeka komzimba nezinto izingxenye ngazinye ukulungiswa. Ngokuvamile ngalinye lala masonto ukusabela isikhathi eside futhi babe nemiphumela ebuhlungu umzimba. Ngakho-ke, i-tablet "Laripront" izingane nabesifazane abakhulelwe kufanele siyisebenzise ngokuqapha.

Ikakhulukazi ngoba izingane ngaso sonke isikhathi uyakwazi ukugcina umlomo ezingemnandi ukuluma lwamafinyila ulwelwesi tablet, futhi avame noma ukugwinya noma ngamathe nje, angazenzi umphumela izidakamizwa kanjalo. Nokho, ukuze izinsana kungenziwa oncibilikiswe eyodwa nane ithebulethi esincane amanzi, elicwiliswe ingxube futhi unike ingane isikhohliso. Kunoma ikuphi, ngaphambi kokuba uqale ukwelapha ezinganeni ngosizo lesi sidakamizwa "Laripront", kubalulekile ukuba uthintane wabantwana.

Njengoba enye, ukunciphisa ukutheleleka in the ngalo ingaphakathi ngomlomo kungasetshenziswa nezinye izidakamizwa e nomphumela ofanayo. Ngokwesibonelo, kusho "Geksoral" ngesimo i aerosol.

Njengoba ukuhambisana nezinye abezindaba kungashiwo ukuthi "Laripront" imithi Umhlahlandlela akusho ukweluleka ukusebenzisa ngokuhlanganyela nabo.

I nomuthi "Laripront" ingasetshenziswa njengendlela agent izifo - ukuphumelela izidakamizwa ingaphezu kwe ngesikhathi reception ngisho at isifo. Futhi kungcono ukuthatha imithi "Laripront" lapho izimpawu zokuqala-SARS.

Ubude yokwelashwa "Laripront" imithi Umhlahlandlela asichazi ngokuqondile. Njenganoma ngomthamo, isikhathi kwesikhathi ukwelashwa incike kwesifo ngokwaso, futhi degree yayo zaba namandla kakhulu. Umthelela umuthi ngamunye - othile kusiza ngokushesha, kodwa abanye bayavuma yini. Kwezinye izimo, ukusetshenziswa kwezimali "Laripront" futhi engalethi noma yimuphi umphumela.